Xuhuai Ji

Xuhuai Ji

Auto-generated profile, based on publicly available information

Xuhuai Ji

Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Science
Verified
Journal Article
Open access
JLJing Li
Jing Li
MZMaxim Zaslavsky
Maxim Zaslavsky
YSYapeng Su
Yapeng Su
JGJing Guo
Jing Guo
MSMichael J. Sikora
Michael J. Sikora
MDMark M Davis
Mark M Davis
In this work, we find that CD8 + T cells expressing inhibitory killer cell immunoglobulin-like receptors (KIRs) are the human equivalent of Ly49 + CD8 + regulatory T cells in mice and are increased in the blood and inflamed tissues of patients with a variety of autoimmune diseases. Moreover, these CD8 + T cells efficiently eliminated pathogenic gliadin-specific CD4 + T cells from the leukocytes of celiac disease patients in vitro. We also find elevated levels of KIR + CD8 + T cells, but not CD4 + regulatory T cells, in COVID-19 patients, correlating with disease severity and vasculitis. Selective ablation of Ly49 + CD8 + T cells in virus-infected mice led to autoimmunity after infection. Our results indicate that in both species, these regulatory CD8 + T cells act specifically to suppress pathogenic T cells in autoimmune and infectious diseases.

9 March 2022 in Science Translational Medicine
Verified
Journal Article
Open access
SCSaborni T Chakraborty
Saborni T Chakraborty
JGJoseph C. Gonzalez
Joseph C. Gonzalez
BSBenjamin Louis Sievers
Benjamin Louis Sievers
VMVamsee Mallajosyula
Vamsee Mallajosyula
SCSrijoni Chakraborty
Srijoni Chakraborty
TWTaia Wang
Taia Wang
A damaging inflammatory response is implicated in the pathogenesis of severe coronavirus disease 2019 (COVID-19), but mechanisms contributing to this response are unclear. In two prospective cohorts, early non-neutralizing, afucosylated immunoglobulin G (IgG) antibodies specific to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were associated with progression from mild to more severe COVID-19. To study the biology of afucosylated IgG immune complexes, we developed an in vivo model that revealed that human IgG–Fc-gamma receptor (FcγR) interactions could regulate inflammation in the lung. Afucosylated IgG immune complexes isolated from patients with COVID-19 induced inflammatory cytokine production and robust infiltration of the lung by immune cells. In contrast to the antibody structures that were associated with disease progression, antibodies that were elicited by messenger RNA SARS-CoV-2 vaccines were highly fucosylated and enriched in sialylation, both modifications that reduce the inflammatory potential of IgG. Vaccine-elicited IgG did not promote an inflammatory lung response. These results show that human IgG-FcγR interactions regulate inflammation in the lung and define distinct lung activities mediated by the IgG that are associated with protection against, or progression to, severe COVID-19.

27 October 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PCPauline P. Chen
Pauline P. Chen
ACAlma-Martina Cepika
Alma-Martina Cepika
RARajni Agarwal
Rajni Agarwal
GSGopin Saini
Gopin Saini
MUMolly J. Uyeda
Molly J. Uyeda
MRMaria Grazia Roncarolo
Maria Grazia Roncarolo
Type 1 regulatory T cells suppress alloreactive immune cells after adoptive transfer in a CTLA-4 and PD-1–mediated manner.

5 August 2024 in PNAS Nexus
Verified
Journal Article
Open access
PDF file
JNJason Nideffer
Jason Nideffer
MTMaureen Ty
Maureen Ty
MDMichele Donato
Michele Donato
RJRek John
Rek John
RKRichard Kajubi
Richard Kajubi
PJPrasanna Jagannathan
Prasanna Jagannathan
The regulation of inflammation is a critical aspect of disease tolerance and naturally acquired clinical immunity to malaria. Here, we demonstrate using RNA sequencing and epigenetic landscape profiling by cytometry by time-of-flight, that the regulation of inflammatory pathways during asymptomatic parasitemia occurs downstream of pathogen sensing—at the epigenetic level. The abundance of certain epigenetic markers (methylation of H3K27 and dimethylation of arginine residues) and decreased prevalence of histone variant H3.3 correlated with suppressed cytokine responses among monocytes of Ugandan children. Such an epigenetic signature was observed across diverse immune cell populations and not only characterized active asymptomatic parasitemia but also correlated with future long-term disease tolerance and clinical immunity when observed in uninfected children. Pseudotime analyses revealed a potential trajectory of epigenetic change that correlated with a child's age and recent parasite exposure and paralleled the acquisition of clinical immunity. Thus, our data support a model whereby exposure to Plasmodium falciparum induces epigenetic changes that regulate excessive inflammation and contribute to naturally acquire clinical immunity to malaria.

4 November 2025 in Nature Immunology
Verified
Journal Article
Open access
PDF file
XHXiaorui Han
Xiaorui Han
VSValeria Skatova
Valeria Skatova
AMArtem Mikelov
Artem Mikelov
XJXuhuai Ji
Xuhuai Ji
RHRamona A. Hoh
Ramona A. Hoh
Kari NadeauKari Nadeau
Kari Nadeau
Oral immunotherapy (OIT) is the only U.S. Food and Drud Administration-approved treatment for peanut allergy. Peanut-reactive (pr) CD4+ T cells are pivotal in peanut allergy pathogenesis and OIT-induced desensitization. However, the underlying pr CD4+ T cell immune mechanisms leading to sustained unresponsiveness after OIT discontinuation are largely unknown. We analyzed single-cell RNA and protein immunophenotypes and T cell receptor repertoires of pr CD4+ T cells from a phase 2 peanut OIT trial cohort. We identified increased cytotoxicity-related phenotypes and type 1 helper cytotoxic T lymphocyte-like cell clonal expansion during OIT, while type 2 helper T (TH2) cell-related phenotypes and TH2-like cell clonal expansion decreased. OIT participants achieving sustained unresponsiveness were distinguished by lower baseline TH2-related phenotypes, elevated post-OIT cytotoxicity-related pr effector T cell gene signatures and higher CD39 expression in pr regulatory T cells. These findings clarify OIT-induced CD4+ T cell tolerance mechanisms and can guide effective allergen-specific OIT strategies.

25 December 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJing Li
Jing Li
MZMaxim Elisha Zaslavsky
Maxim Elisha Zaslavsky
YSYapeng Su
Yapeng Su
MSMichael J. Sikora
Michael J. Sikora
VUVincent van Unen
Vincent van Unen
MDMark M Davis
Mark M Davis
Previous reports show that Ly49 + CD8 + T cells can suppress autoimmunity in mouse models of autoimmune diseases. Here we find a markedly increased frequency of CD8 + T cells expressing inhibitory Killer cell Immunoglobulin like Receptors (KIR), the human equivalent of the Ly49 family, in the blood and inflamed tissues of various autoimmune diseases. Moreover, KIR + CD8 + T cells can efficiently eliminate pathogenic gliadin-specific CD4 + T cells from Celiac disease (CeD) patients’ leukocytes in vitro . Furthermore, we observe elevated levels of KIR + CD8 + T cells, but not CD4 + regulatory T cells, in COVID-19 and influenza-infected patients, and this correlates with disease severity and vasculitis in COVID-19. Expanded KIR + CD8 + T cells from these different diseases display shared phenotypes and similar T cell receptor sequences. These results characterize a regulatory CD8 + T cell subset in humans, broadly active in both autoimmune and infectious diseases, which we hypothesize functions to control self-reactive or otherwise pathogenic T cells. One-Sentence Summary: Here we identified KIR + CD8 + T cells as a regulatory CD8 + T cell subset in humans that suppresses self-reactive or otherwise pathogenic CD4 + T cells.